U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C38H69NO14
Molecular Weight 763.9528
Optical Activity UNSPECIFIED
Defined Stereocenters 19 / 19
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 14-(R)-Hydroxyclarithromycin

SMILES

CO[C@]1(C)C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@H](OC(=O)[C@@H]2C)[C@@H](C)O)OC)O[C@@H](C)[C@@H]1O

InChI

InChIKey=BLPFDXNVUDZBII-KTDRUCRASA-N
InChI=1S/C38H69NO14/c1-18-16-37(9,48-14)32(53-35-28(42)25(39(11)12)15-19(2)49-35)21(4)29(51-26-17-36(8,47-13)31(44)24(7)50-26)22(5)34(45)52-33(23(6)40)38(10,46)30(43)20(3)27(18)41/h18-26,28-33,35,40,42-44,46H,15-17H2,1-14H3/t18-,19-,20+,21+,22-,23-,24+,25+,26+,28-,29+,30-,31+,32-,33-,35+,36-,37-,38+/m1/s1

HIDE SMILES / InChI

Molecular Formula C38H69NO14
Molecular Weight 763.9528
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 19 / 19
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 20:30:37 GMT 2025
Edited
by admin
on Wed Apr 02 20:30:37 GMT 2025
Record UNII
QS9JUX3AKY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
14-(R)-Hydroxyclarithromycin
Common Name English
(14R)-14-Hydroxyclarithromycin
Preferred Name English
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetra hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexa
Systematic Name English
Erythromycin, 14-hydroxy-6-O-methyl-, (14R)-
Common Name English
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dion
Systematic Name English
Code System Code Type Description
FDA UNII
QS9JUX3AKY
Created by admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
PRIMARY
PUBCHEM
13921565
Created by admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
PRIMARY
CAS
116836-41-0
Created by admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Name Property Type Amount Referenced Substance Defining Parameters References
MIC BIOLOGICAL PATHOGEN: S. PYOGENES, S. PNEUMONIAE, H. PYLORI

SUSCEPTIBILITY: RESISTANT

Biological Half-life PHARMACOKINETIC 14-OH-CLARITHROMYCIN

MIC BIOLOGICAL PATHOGEN: S. AUREUS

SUSCEPTIBILITY: RESISTANT

MIC BIOLOGICAL PATHOGEN: H. INFLUENZAE

SUSCEPTIBILITY: SUSCEPTIBLE

MIC BIOLOGICAL SUSCEPTIBILITY: SUSCEPTIBLE

PATHOGEN: S. PYOGENES, S. PNEUMONIAE, H. PYLORI

MIC BIOLOGICAL SUSCEPTIBILITY: INTERMEDIATE

PATHOGEN: S. AUREUS

MIC BIOLOGICAL PATHOGEN: H. INFLUENZAE

SUSCEPTIBILITY: INTERMEDIATE

Biological Half-life PHARMACOKINETIC
MIC BIOLOGICAL PATHOGEN: S. AUREUS

SUSCEPTIBILITY: SUSCEPTIBLE

MIC BIOLOGICAL PATHOGEN: S. PYOGENES, S. PNEUMONIAE

SUSCEPTIBILITY: INTERMEDIATE

MIC BIOLOGICAL SUSCEPTIBILITY: RESISTANT

PATHOGEN: H. INFLUENZAE

Tmax PHARMACOKINETIC FORMULATION: IMMEDIATE RELEASE

Tmax PHARMACOKINETIC FORMULATION: EXTENDED RELEASE

ORAL BIOAVAILABILITY PHARMACOKINETIC